Beta-Adrenergic Blocking Drugs

There are currently six beta-adrenoceptor blocking drugs on the market. Although all the drugs competitively interact with the beta-adrenergic receptors, their pharmacokinetics and ancillary properties distinguish them from one another. By understanding these differences, the various beta-adrenocept...

Full description

Saved in:
Bibliographic Details
Published in:Annual review of medicine 1985-01, Vol.36 (1), p.145-164
Main Authors: Gerber, J G, Nies, A S
Format: Article
Language:English
Subjects:
Adrenergic beta-Antagonists - adverse effects
Adrenergic beta-Antagonists - pharmacology
Adrenergic beta-Antagonists - therapeutic use
Angina Pectoris - drug therapy
Arrhythmias, Cardiac - drug therapy
Biological and medical sciences
Cardiovascular system
Chemical Phenomena
Chemistry
Heart - drug effects
Heart Block - chemically induced
Heart Failure - chemically induced
Humans
Hypertension - drug therapy
Ion Channels - drug effects
Kinetics
Lipids
Medical sciences
Miscellaneous
Myocardial Infarction - prevention & control
Pharmacology. Drug treatments
Raynaud Disease - chemically induced
Sodium - metabolism
Substance Withdrawal Syndrome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a402t-ed14a455bba512e1203d1759b3deaaa610f075ed23dac694b60795afb8f560cf3
cites
container_end_page 164
container_issue 1
container_start_page 145
container_title Annual review of medicine
container_volume 36
creator Gerber, J G
Nies, A S
description There are currently six beta-adrenoceptor blocking drugs on the market. Although all the drugs competitively interact with the beta-adrenergic receptors, their pharmacokinetics and ancillary properties distinguish them from one another. By understanding these differences, the various beta-adrenoceptor drugs can be rationally used to a therapeutic advantage.
doi_str_mv 10.1146/annurev.me.36.020185.001045
format article
fullrecord <record><control><sourceid>annualreviews_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_9267519</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>n/a</sourcerecordid><originalsourceid>FETCH-LOGICAL-a402t-ed14a455bba512e1203d1759b3deaaa610f075ed23dac694b60795afb8f560cf3</originalsourceid><addsrcrecordid>eNqVj0tLw0AQxxdRaq1-BKWg18SZfSWLF9v6hIIXBW_LJNmUaJKW3Vbx25uS4N3THP6v-TF2iRAjSn1Nbbvz7ituXCx0DBwwVTEAglQHbIxKqkhw_X7IxgBaR5KjOWYnIXwAgBEiHbERVylKk47ZxdxtKZoV3rXOr6p8Oq_X-WfVrqZ3frcKp-yopDq4s-FO2NvD_eviKVq-PD4vZsuIJPBt5AqUJJXKMlLIHXIQBSbKZKJwRKQRSkiUK7goKNdGZhoSo6jM0lJpyEsxYTd9b-7XIXhX2o2vGvI_FsHuoe0AbRtnhbY9tO2hu_R5n97sssYVf9mBstOvBp1CTnXpqc2r8GczXCcKTWe77W37Laq7tcp9h3998gu1cXch</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Beta-Adrenergic Blocking Drugs</title><source>Annual Reviews</source><source>Annual Reviews Back Volume Collection</source><creator>Gerber, J G ; Nies, A S</creator><creatorcontrib>Gerber, J G ; Nies, A S</creatorcontrib><description>There are currently six beta-adrenoceptor blocking drugs on the market. Although all the drugs competitively interact with the beta-adrenergic receptors, their pharmacokinetics and ancillary properties distinguish them from one another. By understanding these differences, the various beta-adrenoceptor drugs can be rationally used to a therapeutic advantage.</description><identifier>ISSN: 0066-4219</identifier><identifier>EISSN: 1545-326X</identifier><identifier>DOI: 10.1146/annurev.me.36.020185.001045</identifier><identifier>PMID: 2581498</identifier><identifier>CODEN: ARMCAH</identifier><language>eng</language><publisher>Palo Alto, CA 94303-0139: Annual Reviews</publisher><subject>Adrenergic beta-Antagonists - adverse effects ; Adrenergic beta-Antagonists - pharmacology ; Adrenergic beta-Antagonists - therapeutic use ; Angina Pectoris - drug therapy ; Arrhythmias, Cardiac - drug therapy ; Biological and medical sciences ; Cardiovascular system ; Chemical Phenomena ; Chemistry ; Heart - drug effects ; Heart Block - chemically induced ; Heart Failure - chemically induced ; Humans ; Hypertension - drug therapy ; Ion Channels - drug effects ; Kinetics ; Lipids ; Medical sciences ; Miscellaneous ; Myocardial Infarction - prevention &amp; control ; Pharmacology. Drug treatments ; Raynaud Disease - chemically induced ; Sodium - metabolism ; Substance Withdrawal Syndrome</subject><ispartof>Annual review of medicine, 1985-01, Vol.36 (1), p.145-164</ispartof><rights>1985 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a402t-ed14a455bba512e1203d1759b3deaaa610f075ed23dac694b60795afb8f560cf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.annualreviews.org/content/journals/10.1146/annurev.me.36.020185.001045?crawler=true&amp;mimetype=application/pdf$$EPDF$$P50$$Gannualreviews$$H</linktopdf><linktohtml>$$Uhttps://www.annualreviews.org/content/journals/10.1146/annurev.me.36.020185.001045$$EHTML$$P50$$Gannualreviews$$H</linktohtml><link.rule.ids>70,314,780,784,4182,27924,27925,78254,78255,78274,78379</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9267519$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2581498$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerber, J G</creatorcontrib><creatorcontrib>Nies, A S</creatorcontrib><title>Beta-Adrenergic Blocking Drugs</title><title>Annual review of medicine</title><addtitle>Annu Rev Med</addtitle><description>There are currently six beta-adrenoceptor blocking drugs on the market. Although all the drugs competitively interact with the beta-adrenergic receptors, their pharmacokinetics and ancillary properties distinguish them from one another. By understanding these differences, the various beta-adrenoceptor drugs can be rationally used to a therapeutic advantage.</description><subject>Adrenergic beta-Antagonists - adverse effects</subject><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Angina Pectoris - drug therapy</subject><subject>Arrhythmias, Cardiac - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Chemical Phenomena</subject><subject>Chemistry</subject><subject>Heart - drug effects</subject><subject>Heart Block - chemically induced</subject><subject>Heart Failure - chemically induced</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Ion Channels - drug effects</subject><subject>Kinetics</subject><subject>Lipids</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Myocardial Infarction - prevention &amp; control</subject><subject>Pharmacology. Drug treatments</subject><subject>Raynaud Disease - chemically induced</subject><subject>Sodium - metabolism</subject><subject>Substance Withdrawal Syndrome</subject><issn>0066-4219</issn><issn>1545-326X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><recordid>eNqVj0tLw0AQxxdRaq1-BKWg18SZfSWLF9v6hIIXBW_LJNmUaJKW3Vbx25uS4N3THP6v-TF2iRAjSn1Nbbvz7ituXCx0DBwwVTEAglQHbIxKqkhw_X7IxgBaR5KjOWYnIXwAgBEiHbERVylKk47ZxdxtKZoV3rXOr6p8Oq_X-WfVrqZ3frcKp-yopDq4s-FO2NvD_eviKVq-PD4vZsuIJPBt5AqUJJXKMlLIHXIQBSbKZKJwRKQRSkiUK7goKNdGZhoSo6jM0lJpyEsxYTd9b-7XIXhX2o2vGvI_FsHuoe0AbRtnhbY9tO2hu_R5n97sssYVf9mBstOvBp1CTnXpqc2r8GczXCcKTWe77W37Laq7tcp9h3998gu1cXch</recordid><startdate>19850101</startdate><enddate>19850101</enddate><creator>Gerber, J G</creator><creator>Nies, A S</creator><general>Annual Reviews</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19850101</creationdate><title>Beta-Adrenergic Blocking Drugs</title><author>Gerber, J G ; Nies, A S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a402t-ed14a455bba512e1203d1759b3deaaa610f075ed23dac694b60795afb8f560cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Adrenergic beta-Antagonists - adverse effects</topic><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Angina Pectoris - drug therapy</topic><topic>Arrhythmias, Cardiac - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Chemical Phenomena</topic><topic>Chemistry</topic><topic>Heart - drug effects</topic><topic>Heart Block - chemically induced</topic><topic>Heart Failure - chemically induced</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Ion Channels - drug effects</topic><topic>Kinetics</topic><topic>Lipids</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Myocardial Infarction - prevention &amp; control</topic><topic>Pharmacology. Drug treatments</topic><topic>Raynaud Disease - chemically induced</topic><topic>Sodium - metabolism</topic><topic>Substance Withdrawal Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerber, J G</creatorcontrib><creatorcontrib>Nies, A S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annual review of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerber, J G</au><au>Nies, A S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beta-Adrenergic Blocking Drugs</atitle><jtitle>Annual review of medicine</jtitle><addtitle>Annu Rev Med</addtitle><date>1985-01-01</date><risdate>1985</risdate><volume>36</volume><issue>1</issue><spage>145</spage><epage>164</epage><pages>145-164</pages><issn>0066-4219</issn><eissn>1545-326X</eissn><coden>ARMCAH</coden><abstract>There are currently six beta-adrenoceptor blocking drugs on the market. Although all the drugs competitively interact with the beta-adrenergic receptors, their pharmacokinetics and ancillary properties distinguish them from one another. By understanding these differences, the various beta-adrenoceptor drugs can be rationally used to a therapeutic advantage.</abstract><cop>Palo Alto, CA 94303-0139</cop><cop>4139 El Camino Way, P.O. Box 10139</cop><cop>USA</cop><pub>Annual Reviews</pub><pmid>2581498</pmid><doi>10.1146/annurev.me.36.020185.001045</doi><tpages>20</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0066-4219
ispartof Annual review of medicine, 1985-01, Vol.36 (1), p.145-164
issn 0066-4219
1545-326X
language eng
recordid cdi_pascalfrancis_primary_9267519
source Annual Reviews; Annual Reviews Back Volume Collection
subjects Adrenergic beta-Antagonists - adverse effects
Adrenergic beta-Antagonists - pharmacology
Adrenergic beta-Antagonists - therapeutic use
Angina Pectoris - drug therapy
Arrhythmias, Cardiac - drug therapy
Biological and medical sciences
Cardiovascular system
Chemical Phenomena
Chemistry
Heart - drug effects
Heart Block - chemically induced
Heart Failure - chemically induced
Humans
Hypertension - drug therapy
Ion Channels - drug effects
Kinetics
Lipids
Medical sciences
Miscellaneous
Myocardial Infarction - prevention & control
Pharmacology. Drug treatments
Raynaud Disease - chemically induced
Sodium - metabolism
Substance Withdrawal Syndrome
title Beta-Adrenergic Blocking Drugs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A53%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-annualreviews_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beta-Adrenergic%20Blocking%20Drugs&rft.jtitle=Annual%20review%20of%20medicine&rft.au=Gerber,%20J%20G&rft.date=1985-01-01&rft.volume=36&rft.issue=1&rft.spage=145&rft.epage=164&rft.pages=145-164&rft.issn=0066-4219&rft.eissn=1545-326X&rft.coden=ARMCAH&rft_id=info:doi/10.1146/annurev.me.36.020185.001045&rft_dat=%3Cannualreviews_pasca%3En/a%3C/annualreviews_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a402t-ed14a455bba512e1203d1759b3deaaa610f075ed23dac694b60795afb8f560cf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/2581498&rfr_iscdi=true